This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
5-MeO-DALT was first synthesized by [[Alexander Shulgin]], who sent the first material regarding the synthesis and effects to a researcher in May 2004. This material was subsequently circulated online and the compound soon appeared on the online [[research chemical]] market.
5-MeO-DALT was first synthesized by [[Alexander Shulgin]], who sent the first material regarding the synthesis and effects to a researcher in May 2004. This material was subsequently circulated online and the compound soon appeared on the online [[research chemical]] market.
In August 2004, the synthesis and effects of 5-MeO-DALT were officially published by Erowid.<ref>http://www.vice.com/en_uk/read/the-last-interview-with-alexander-shulgin-423-v17n5</ref> Reports linked to the detection of 5-MeO-DALT began to surface in 2007.<ref name="brandt">Brandt, S. D., Kavanagh, P. V., Dowling, G., Talbot, B., Westphal, F., Meyer, M. R., ... & Halberstadt, A. L. (2017). Analytical characterization of N, N‐diallyltryptamine (DALT) and 16 ring‐substituted derivatives. Drug Testing and Analysis, 9(1), 115-126. https://doi.org/10.1002/dta.1974</ref>
In August 2004, the synthesis and effects of 5-MeO-DALT were officially published by Erowid.<ref>{{cite news|title=The Last Interview With Alexander Shulgin|url=https://www.vice.com/en_uk/article/avjewz/the-last-interview-with-alexander-shulgin-423-v17n5|author1=Hamilton Morris|author2=Ash Smith|date=May 2, 2010|website=vice.com|access-date=August 28, 2020}}</ref> Reports linked to the detection of 5-MeO-DALT began to surface in 2007.<ref name="brandt">{{cite journal|last1=Brandt|first1=S. D.|last2=Kavanagh|first2=P. V.|last3=Dowling|first3=G.|last4=Talbot|first4=B.|last5=Westphal|first5=F.|last6=Meyer|first6=M. R.|first7=H. H.|last7=Maurer|last8=Halberstadt|first8=A. L.|year=2017|title=Analytical characterization of N, N‐diallyltryptamine (DALT) and 16 ring‐substituted derivatives|journal=Drug Testing and Analysis|volume=9|issue=1|pages=115-126|doi=10.1002/dta.1974|pmc=5412731|issn=1942-7603|eissn=1942-7611|oclc=231680670|pmid=27100373}}</ref>
Anecdotal reports characterize the effects of this substance as being primarily physical in nature, lacking the characteristic visual distortions or perceptual depth of most psychedelics. Its headspace has been described as "shallow," albeit suited for sexual contexts due to its potent stimulating and libidinous effects.
Anecdotal reports characterize the effects of this substance as being primarily physical in nature, lacking the characteristic visual distortions or perceptual depth of most psychedelics. Its headspace has been described as "shallow," albeit suited for sexual contexts due to its potent stimulating and libidinous effects.
Line 13:
Line 13:
Very limited data exists about the pharmacological properties, metabolism, and toxicity of 5-MeO-DALT, and it has a very short history of human use.
Very limited data exists about the pharmacological properties, metabolism, and toxicity of 5-MeO-DALT, and it has a very short history of human use.
It is highly advised to use [[harm reduction practices]] if using this substance.
It is highly advised to use [[harm reduction practices]] if using this substance.
== Etymology ==
The full name of the chemical is ''N''-allyl-''N''-[2-(5-methoxy-1H-indol-3-yl)ethyl] prop-2-en-1- amine.<ref name=":0">Chadeayne AR, Pham DNK, Golen JA, Manke DR. [https://pmc.ncbi.nlm.nih.gov/articles/PMC9462216/ 5-MeO-DALT: the freebase of N,N-diallyl-5-meth-oxy-tryptamine]. IUCrdata. 2020 Apr 17;5(Pt 4):x200498. doi: 10.1107/S2414314620004988. PMID: 36338299; PMCID: PMC9462216.</ref>
The street name of 5-MeO-DALT is Foxtrot.<ref name=":0" />
==Chemistry==
==Chemistry==
{{chemistry}}
{{chemistry}}
It is related to the compounds 5-MeO-DPT and DALT (N,N-Diallyltryptamine).
5-MeO-DALT is named for its chemical structure 5-MethOxy-DiALlylTryptamine. It contains two allyl groups bound to the amino group and a 5-methoxy group bound to the indole ring of tryptamine. It is a structural analog of [[DALT]] and [[5-MeO-DiPT]]. 5-MeO-DALT is an off-white powder at room temperature.
5-MeO-DALT is named for its chemical structure 5-MethOxy-DiALlylTryptamine. It contains two allyl groups bound to the amino group and a 5-methoxy group bound to the indole ring of tryptamine. It is a structural analog of [[DALT]] and [[5-MeO-DiPT]]. 5-MeO-DALT is an off-white powder at room temperature.
==Pharmacology==
==Pharmacology==
{{Further|Serotonergic psychedelic}}
{{Further|Serotonergic psychedelic}}
5-MeO-DALT acts as a [[Serotonin#The_5-HT_System|5-HT<sub>2A</sub>]] [[Agonist#Agonists|partial agonist]].
5-MeO-DALT binds to 5-HT<sub>1A</sub>, 5-HT<sub>1D</sub>, 5-HT<sub>1E</sub>, 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub>, 5-HT<sub>2C</sub>, 5-HT<sub>6</sub>, α<sub>2A</sub>, α<sub>2B</sub>, α<sub>2C</sub>, H<sub>1</sub>, κ-opioid, σ<sub>1</sub> and σ<sub>2</sub> receptors with K<sub>i</sub> values lower than 10μM and also acts as a DAT and SERT monoamine reuptake inhibitor.<ref>{{cite journal | vauthors=((Cozzi, N. V.)), ((Daley, P. F.)) | journal=Bioorganic & Medicinal Chemistry Letters | title=Receptor binding profiles and quantitative structure–affinity relationships of some 5-substituted- N , N -diallyltryptamines | volume=26 | issue=3 | pages=959–964 | date= February 2016 | url=https://linkinghub.elsevier.com/retrieve/pii/S0960894X1530367X | issn=0960894X | doi=10.1016/j.bmcl.2015.12.053}}</ref>
The [[psychedelic]] effects are believed to come from its efficacy at the 5-HT<sub>2A</sub> receptors. However, the role of these interactions and how they result in the psychedelic experience remains the subject of ongoing scientific investigation.
5-MeO-DALT acts as a [[Serotonin#The_5-HT_System|5-HT<sub>2A</sub>]] [[Agonist#Agonists|partial agonist]]. The [[psychedelic]] effects are believed to come from its efficacy at the 5-HT<sub>2A</sub> receptors. However, the role of these interactions and how they result in the psychedelic experience remains the subject of ongoing scientific investigation.
5-MeO-DALT has been used as an intermediate in the preparation of radiolabeled diethyltryptamine.<ref>{{cite journal | vauthors=((Brandt, S. D.)), ((Tirunarayanapuram, S. S.)), ((Freeman, S.)), ((Dempster, N.)), ((Barker, S. A.)), ((Daley, P. F.)), ((Cozzi, N. V.)), ((Martins, C. P. B.)) | journal=Journal of Labelled Compounds and Radiopharmaceuticals | title=Microwave-accelerated synthesis of psychoactive deuterated N , N -dialkylated-[ α , α , β , β -d 4 ]-tryptamines | volume=51 | issue=14 | pages=423–429 | date= November 2008 | url=https://onlinelibrary.wiley.com/doi/10.1002/jlcr.1557 | issn=03624803 | doi=10.1002/jlcr.1557}}</ref>
==Subjective effects==
==Subjective effects==
{{Preamble/SubjectiveEffects}}
{{Preamble/SubjectiveEffects}}
Line 79:
Line 89:
===Experience reports===
===Experience reports===
There are currently no anecdotal reports which describe the effects of this compound within our [[experience index]]. Additional experience reports can be found here:
There are currently no anecdotal reports which describe the effects of this compound within our [[experience index]]. Additional experience reports can be found here:
{{further|Research chemicals#Toxicity and harm potential|Responsible use #Hallucinogens}}
{{further|Research chemicals#Toxicity and harm potential|Responsible use #Hallucinogens}}
The toxicity and long-term health effects of recreational 5-MeO-DALT use do not seem to have been studied in any scientific context and the exact [[Toxicity::toxic dose is unknown]].
The toxicity and long-term health effects of recreational 5-MeO-DALT use do not seem to have been studied in any scientific context and the exact [[Toxicity::toxic dose is unknown]]. This is because 5-MeO-DALT is a [[research chemical]] with very little history of human usage.
This is because 5-MeO-DALT is a [[research chemical]] with very little history of human usage.
Anecdotal reports from those who have tried 5-MeO-DALT suggests that there are no negative health effects attributed to simply trying the substance by itself at low to moderate doses and using it very sparingly (but nothing can be completely guaranteed). [https://www.google.com/ Independent research] should always be done to ensure that a combination of two or more substances is safe before consumption.
Anecdotal reports from those who have tried 5-MeO-DALT suggests that there are no negative health effects attributed to simply trying the substance by itself at low to moderate doses and using it very sparingly (but nothing can be completely guaranteed). [https://www.google.com/ Independent research] should always be done to ensure that a combination of two or more substances is safe before consumption.
Line 92:
Line 102:
===Tolerance and addiction potential===
===Tolerance and addiction potential===
5-MeO-DALT is [[Addiction potential::not habit-forming]] and the desire to use it can actually decrease with use. It is most often self-regulating.
5-MeO-DALT is [[Addiction potential::not habit-forming]], and the desire to use it can actually decrease with use. It is most often self-regulating.
Tolerance to the effects of 5-MeO-DALT are built [[Time to full tolerance::almost immediately after ingestion]].
Tolerance to the effects of 5-MeO-DALT is built [[Time to full tolerance::almost immediately after ingestion]].
After that, it takes about [[Time to half tolerance::3 days]] for the tolerance to be reduced to half and [[Time to zero tolerance::7 days]] to be back at baseline (in the absence of further consumption).
After that, it takes about [[Time to half tolerance::3 days]] for the tolerance to be reduced to half and [[Time to zero tolerance::7 days]] to be back at baseline (in the absence of further consumption).
5-MeO-DALT presents cross-tolerance with [[Cross-tolerance::all [[psychedelic]]s]], meaning that after the consumption of 5-MeO-DALT all psychedelics will have a reduced effect.
5-MeO-DALT presents cross-tolerance with [[Cross-tolerance::all [[psychedelic]]s]], meaning that after the consumption of 5-MeO-DALT all psychedelics will have a reduced effect.
===Dangerous interactions===
{{DangerousInteractions/Intro}}
{{DangerousInteractions/5-MeO-xxT}}
==Legal status==
==Legal status==
*'''Austria:''' Since January 1, 2012, 5-MeO-DALT is illegal to possess, produce and sell under the NPSG (Neue-Psychoaktive-Substanzen-Gesetz Österreich).{{citation needed}}
*'''China:''' 5-MeO-DALT is a controlled substance in China as of October 2015.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=Chinese | accessdate=1 October 2015}}</ref>
*'''Austria''': Since January 1, 2012, 5-MeO-DALT is illegal to possess, produce and sell under the NPSG (Neue-Psychoaktive-Substanzen-Gesetz Österreich).{{citation needed}}
*'''Japan:''' 5-MeO-DALT became a controlled substance in Japan in April 2007 due to an amendment to the Pharmaceutical Affairs Law.<ref>{{ cite web | url = http://www.mhlw.go.jp/houdou/2007/08/h0810-3.html | title = 厚生労働省：平成１8年度無承認無許可医薬品等買上調査の結果について | accessdate = 2012-06-26 }}</ref>
*'''China''': 5-MeO-DALT is a controlled substance in China as of October 2015.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html|title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=国家食品药品监督管理总局 [China Food and Drug Administration]|date=September 27, 2015 |language=Chinese| accessdate=1 October 2015}}</ref>
*'''Sweden:''' 5-MeO-DALT is a Schedule I substance in Sweden as of May 1, 2012. It was published by ''Medical Products Agency'' in their regulation ''LVFS 2012:6''.<ref>http://www.lakemedelsverket.se/upload/lvfs/LVFS_2012_6.pdf</ref>
*'''Germany''': 5-MeO-DALT is controlled under the NpSG<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/anlage.html|title=Anlage NpSG|publisher=Bundesamt für Justiz [Federal Office of Justice]|access-date=December 10, 2019|language=de}}</ref> (''New Psychoactive Substances Act'') as of July 18, 2019.<ref>{{cite web|url=http://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&jumpTo=bgbl119s1083.pdf|title=Verordnung zur Änderung der Anlage des Neue-psychoaktive-Stoffe-Gesetzes und von Anlagen des Betäubungsmittelgesetzes|publisher=Bundesanzeiger Verlag|work=Bundesgesetzblatt Jahrgang 2019 Teil I Nr. 27|pages=1083-1094|date=July 12, 2019|publication-date=July 17, 2019|language=de|issn=0341-1095}}</ref> Production and import with the aim to place it on the market, administration to another person, placing it on the market and trading is punishable. Possession is illegal but not punishable.<ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/__4.html|title=§ 4 NpSG|publisher=Bundesamt für Justiz [Federal Office of Justice]|access-date=December 10, 2019|language=de}}</ref><ref>{{cite web|url=https://www.gesetze-im-internet.de/npsg/__3.html|title=§ 3 NpSG|publisher=Bundesamt für Justiz [Federal Office of Justice]|access-date=December 10, 2019|language=de}}</ref> The legislator considers it possible that orders of 5-MeO-DALT are punishable as an incitement to place it on the market.<ref>{{cite web|url=http://dip21.bundestag.de/dip21/btd/18/085/1808579.pdf|title=Gesetzentwurf der Bundesregierung: Entwurf eines Gesetzes zur Bekämpfung der Verbreitung neuer psychoaktiver Stoffe|page=20|date=May 30, 2016|id=Drucksache 18/8579|publisher=Deutscher Bundestag|language=de}}</ref>
*'''United Kingdom:''' 5-MeO-DALT is a Class A drug in the UK as it is an ether of the drug 5-HO-DALT,<ref>Misuse of Drugs Act 1971 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/1971/38/schedule/2/part/I/paragraph/3</ref> which is a Class A drug as a result of the tryptamine catch-all clause.<ref>Misuse of Drugs Act 1971 (Legislation.gov.uk) |http://www.legislation.gov.uk/ukpga/1971/38/schedule/2/part/I#reference-M_F_c7632653-ddad-4420-f307-e3da1e36d30e</ref>
*'''Japan''': 5-MeO-DALT became a controlled substance in Japan in April 2007 due to an amendment to the Pharmaceutical Affairs Law.<ref>{{cite web|url=http://www.mhlw.go.jp/houdou/2007/08/h0810-3.html|title=厚生労働省：平成１8年度無承認無許可医薬品等買上調査の結果について|date=August 10, 2007|access-date=June 26, 2012|publisher=厚生労働省 [Ministry of Health, Labour and Welfare (MHLW)]|language=ja}}</ref>
*'''United States:''' 5-MeO-DALT is unscheduled in the United States. It may be considered an analogue of [[5-MeO-DiPT]], a Schedule I drug under the Controlled Substances Act. As such, the sale for human consumption or the use for illicit non-medical or industrial intents and purposes could be prosecuted as crimes under the Federal Analogue Act.{{citation needed}}
*'''Sweden''': 5-MeO-DALT is a Schedule I substance in Sweden as of May 1, 2012. It was published by ''Medical Products Agency'' in their regulation ''LVFS 2012:6''.<ref>{{cite web|url=https://lakemedelsverket.se/upload/lvfs/LVFS_2012_6.pdf|archive-url=https://web.archive.org/web/20181031222225/https://lakemedelsverket.se/upload/lvfs/LVFS_2012_6.pdf|archive-date=October 31, 2018|title=Föreskrifter om ändring i Läkemedelsverkets föreskrifter (LVFS 2011:10) om förteckningar över narkotika|date=April 20, 2012|id=LVFS 2012:6|publication-date=April 30, 2012|issn=1101-5225|publisher=Läkemedelsverket [Medical Products Agency ]|language=sv}}</ref>
**'''Florida:''' 5-MeO-DALT is a Schedule I controlled substance in the state of Florida, making it illegal to buy, sell, or possess.<ref name="Florida Statutes - Chapter 893 - DRUG ABUSE PREVENTION AND CONTROL">[http://leg.state.fl.us/statutes/index.cfm?App_mode=Display_Statute&URL=0800-0899/0893/0893.html Florida Statutes - Chapter 893 - DRUG ABUSE PREVENTION AND CONTROL]</ref>
*'''Slovakia''' : 5-MeO-DALT is a Schedule I substance in Slovakia as of December 1, 2021
*'''Switzerland''': 5-MeO-DALT is a controlled substance specifically named under Verzeichnis E.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref>
*'''United Kingdom''': 5-MeO-DALT is a Class A drug in the UK as it is an ether of the drug 5-HO-DALT, which is a Class A drug as a result of the tryptamine catch-all clause.<ref>{{cite web|title=Schedule 2: Part I: Class A Drugs|url=http://www.legislation.gov.uk/ukpga/1971/38/schedule/2/part/I|work="Misuse of Drugs Act 1971"|access-date=August 20, 2020|publisher=UK Government}}</ref>
*'''United States''': 5-MeO-DALT is unscheduled in the United States. It may be considered an analogue of [[5-MeO-DiPT]], a Schedule I drug under the Controlled Substances Act. As such, the sale for human consumption or the use for illicit non-medical or industrial intents and purposes could be prosecuted as crimes under the Federal Analogue Act.{{citation needed}}
**'''Florida''': 5-MeO-DALT is a Schedule I controlled substance in the state of Florida, making it illegal to buy, sell, or possess.<ref>{{cite web|url=http://leg.state.fl.us/statutes/index.cfm?App_mode=Display_Statute&URL=0800-0899/0893/0893.html|work=The 2019 Florida Statutes|title=Chapter 893: Drug Abuse Prevention and Control|publisher=The Florida Legislature|access-date=August 21, 2020}}</ref>
*[https://www.drugs-forum.com/forum/showthread.php?t=4054 Drugs Forum 5-MeO-DALT thread]
===Discussion===
*[https://www.ukchemicalresearch.org/Thread-5-MeO-DALT UK Chemical Research 5-MeO-DALT thread]
*[https://www.ukchemicalresearch.org/Thread-5-MeO-DALT UK Chemical Research 5-MeO-DALT thread]
*[http://www.bluelight.org/vb/threads/146249-The-Big-amp-Dandy-5-MeO-DALT-Thread The Big & Dandy 5-MeO-DALT Thread]
==Literature==
==Literature==
* Brandt, S. D., Kavanagh, P. V., Dowling, G., Talbot, B., Westphal, F., Meyer, M. R., ... & Halberstadt, A. L. (2017). Analytical characterization of N, N‐diallyltryptamine (DALT) and 16 ring‐substituted derivatives. Drug Testing and Analysis, 9(1), 115-126. https://doi.org/10.1002/dta.1974
*Brandt, S. D., Kavanagh, P. V., Dowling, G., Talbot, B., Westphal, F., Meyer, M. R., ... & Halberstadt, A. L. (2017). Analytical characterization of N, N‐diallyltryptamine (DALT) and 16 ring‐substituted derivatives. Drug Testing and Analysis, 9(1), 115-126. https://doi.org/10.1002/dta.1974
WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.
DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.
N,N-Diallyl-5-methoxytryptamine (also known as 5-MeO-DALT or colloquially as Foxtrot) is a lesser-known psychedelic substance of the tryptamine class that produces short-lived psychedelic effects when administered.
It is structurally related to tryptamines like 5-MeO-DiPT and DALT, although it is reported to produce distinct effects.
5-MeO-DALT was first synthesized by Alexander Shulgin, who sent the first material regarding the synthesis and effects to a researcher in May 2004. This material was subsequently circulated online and the compound soon appeared on the online research chemical market.
In August 2004, the synthesis and effects of 5-MeO-DALT were officially published by Erowid.[1] Reports linked to the detection of 5-MeO-DALT began to surface in 2007.[2]
Anecdotal reports characterize the effects of this substance as being primarily physical in nature, lacking the characteristic visual distortions or perceptual depth of most psychedelics. Its headspace has been described as "shallow," albeit suited for sexual contexts due to its potent stimulating and libidinous effects.
It is also reported to produce more uncomfortable cardiovascular effects such as increased blood pressure and heart rate relative to other psychedelics. This has raised questions about possible toxicity associated with long-term or heavy uses.
Very limited data exists about the pharmacological properties, metabolism, and toxicity of 5-MeO-DALT, and it has a very short history of human use.
It is highly advised to use harm reduction practices if using this substance.
It is related to the compounds 5-MeO-DPT and DALT (N,N-Diallyltryptamine).
5-MeO-DALT is named for its chemical structure 5-MethOxy-DiALlylTryptamine. It contains two allyl groups bound to the amino group and a 5-methoxy group bound to the indole ring of tryptamine. It is a structural analog of DALT and 5-MeO-DiPT. 5-MeO-DALT is an off-white powder at room temperature.
5-MeO-DALT binds to 5-HT1A, 5-HT1D, 5-HT1E, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT6, α2A, α2B, α2C, H1, κ-opioid, σ1 and σ2 receptors with Ki values lower than 10μM and also acts as a DAT and SERT monoamine reuptake inhibitor.[4]
5-MeO-DALT acts as a 5-HT2Apartial agonist. The psychedelic effects are believed to come from its efficacy at the 5-HT2A receptors. However, the role of these interactions and how they result in the psychedelic experience remains the subject of ongoing scientific investigation.
5-MeO-DALT has been used as an intermediate in the preparation of radiolabeled diethyltryptamine.[5]
Subjective effects
Disclaimer: The effects listed below cite the Subjective Effect Index (SEI), an open research literature based on anecdotal user reports and the personal analyses of PsychonautWikicontributors. As a result, they should be viewed with a healthy degree of skepticism.
It is also worth noting that these effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects. Likewise, adverse effects become increasingly likely with higher doses and may include addiction, severe injury, or death ☠.
Spontaneous physical sensations - The "body high" of 5-MeO-DALT can be described as a motionless, constant, sharp and all-encompassing tingling sensation. This maintains a consistent presence that steadily rises with the come up and hits its limit once the peak has been reached.
Drifting(melting, flowing, breathing and morphing) - In comparison to other psychedelics, this effect can be described as simplistic, slow and smooth in motion, static in appearance and unrealistic in style.
The visual geometry that is present throughout the experience can be described as more similar in appearance to that of AMT than that of LSD, 2C-B or 2C-I.
It can be comprehensively described as unstructured in its organization, synthetic in geometric style, intricate in complexity, small in size, slow and smooth in motion, colourful in scheme, glossy in colour, equally blurred and sharp in its edges and equally rounded and angular in its corners.
It possesses a synthetic feel that is less impressive than most of the "classical" psychedelics at any level. It has yet to be confirmed whether this compound results in either level 8A or level 8B geometry at heavy doses.
Cognitive effects
The headspace of 5-MeO-DALT is described by many as one which is both insightful and relatively normal in its thought processes even at moderate to high doses.
There are currently no anecdotal reports which describe the effects of this compound within our experience index. Additional experience reports can be found here:
This toxicity and harm potential section is a stub.
As a result, it may contain incomplete or even dangerously wrong information! You can help by expanding upon or correcting it. Note: Always conduct independent research and use harm reduction practices if using this substance.
The toxicity and long-term health effects of recreational 5-MeO-DALT use do not seem to have been studied in any scientific context and the exact toxic dose is unknown. This is because 5-MeO-DALT is a research chemical with very little history of human usage.
Anecdotal reports from those who have tried 5-MeO-DALT suggests that there are no negative health effects attributed to simply trying the substance by itself at low to moderate doses and using it very sparingly (but nothing can be completely guaranteed). Independent research should always be done to ensure that a combination of two or more substances is safe before consumption.
5-MeO-DALT is not habit-forming, and the desire to use it can actually decrease with use. It is most often self-regulating.
Tolerance to the effects of 5-MeO-DALT is built almost immediately after ingestion.
After that, it takes about 3 days for the tolerance to be reduced to half and 7 days to be back at baseline (in the absence of further consumption).
5-MeO-DALT presents cross-tolerance with [[Cross-tolerance::all psychedelics]], meaning that after the consumption of 5-MeO-DALT all psychedelics will have a reduced effect.
Dangerous interactions
Warning:Many psychoactive substances that are reasonably safe to use on their own can suddenly become dangerous and even life-threatening when combined with certain other substances. The following list provides some known dangerous interactions (although it is not guaranteed to include all of them).
Always conduct independent research (e.g. Google, DuckDuckGo, PubMed) to ensure that a combination of two or more substances is safe to consume. Some of the listed interactions have been sourced from TripSit.
2C-T-X - Both classes of compounds can be unpredictable alone.
2C-X - The 5-MeO psychedelics can interact unpredictably to potentiate other psychedelics.
Cannabis - May increase the risk of negative psychological effects such as anxiety, paranoia, and psychosis.
DOx - The 5-MeO class of tryptamines can be unpredictable in their interactions, particularly increasing the risk of unpleasant physical side effects.
MDMA - Some of the 5-MeO tryptamines are a bit unpredictable and should be mixed with MDMA with care.
Mescaline - The 5-MeO class of tryptamines can be unpredictable in their interactions.
NBOMe - The 5-MeO class of tryptamines can be unpredictable in their interactions and the NBOMes are known to be unpredictable even alone. This combination is best avoided.
Amphetamines - The anxiogenic and focusing effects of stimulants increase the chance of unpleasant thought loops. The combination is generally unnecessary because of the stimulating effects of psychedelics.
Cocaine - The anxiogenic and focusing effects of stimulants increase the chance of unpleasant thought loops. The combination is generally unnecessary because of the stimulating effects of psychedelics.
DXM - Little information exists about this combination.
PCP - Little information exists about this combination. May increase risk of psychosis and excessive stimulation.
Legal status
Austria: Since January 1, 2012, 5-MeO-DALT is illegal to possess, produce and sell under the NPSG (Neue-Psychoaktive-Substanzen-Gesetz Österreich).[citation needed]
China: 5-MeO-DALT is a controlled substance in China as of October 2015.[6]
Germany: 5-MeO-DALT is controlled under the NpSG[7] (New Psychoactive Substances Act) as of July 18, 2019.[8] Production and import with the aim to place it on the market, administration to another person, placing it on the market and trading is punishable. Possession is illegal but not punishable.[9][10] The legislator considers it possible that orders of 5-MeO-DALT are punishable as an incitement to place it on the market.[11]
Japan: 5-MeO-DALT became a controlled substance in Japan in April 2007 due to an amendment to the Pharmaceutical Affairs Law.[12]
Sweden: 5-MeO-DALT is a Schedule I substance in Sweden as of May 1, 2012. It was published by Medical Products Agency in their regulation LVFS 2012:6.[13]
Slovakia : 5-MeO-DALT is a Schedule I substance in Slovakia as of December 1, 2021
Switzerland: 5-MeO-DALT is a controlled substance specifically named under Verzeichnis E.[14]
United Kingdom: 5-MeO-DALT is a Class A drug in the UK as it is an ether of the drug 5-HO-DALT, which is a Class A drug as a result of the tryptamine catch-all clause.[15]
United States: 5-MeO-DALT is unscheduled in the United States. It may be considered an analogue of 5-MeO-DiPT, a Schedule I drug under the Controlled Substances Act. As such, the sale for human consumption or the use for illicit non-medical or industrial intents and purposes could be prosecuted as crimes under the Federal Analogue Act.[citation needed]
Florida: 5-MeO-DALT is a Schedule I controlled substance in the state of Florida, making it illegal to buy, sell, or possess.[16]
Brandt, S. D., Kavanagh, P. V., Dowling, G., Talbot, B., Westphal, F., Meyer, M. R., ... & Halberstadt, A. L. (2017). Analytical characterization of N, N‐diallyltryptamine (DALT) and 16 ring‐substituted derivatives. Drug Testing and Analysis, 9(1), 115-126. https://doi.org/10.1002/dta.1974
↑"关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). 国家食品药品监督管理总局 [China Food and Drug Administration]. September 27, 2015. Retrieved 1 October 2015.CS1 maint: Unrecognized language (link)
↑"Anlage NpSG" (in Deutsch). Bundesamt für Justiz [Federal Office of Justice]. Retrieved December 10, 2019.
. PMID 27100373.